Fibroblast Growth Factors
-
Subject Areas on Research
-
(1-34) Parathyroid hormone infusion acutely lowers fibroblast growth factor 23 concentrations in adult volunteers.
-
A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5.
-
A Comparative Study of Serum Phosphate and Related Parameters in Chronic Kidney Disease between the USA and Japan.
-
A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD.
-
A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation.
-
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis.
-
A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease.
-
A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism.
-
A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive.
-
Acid Load and Phosphorus Homeostasis in CKD.
-
Acidic fibroblast growth factor enhances peripheral nerve regeneration in vivo.
-
Acidic fibroblast growth factor enhances regeneration of processes by postnatal mammalian retinal ganglion cells in culture.
-
Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy.
-
Activation of fibroblast growth factor (FGF) receptors by recombinant human FGF-5.
-
Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial.
-
Alpha 2-macroglobulin is a binding protein for basic fibroblast growth factor.
-
Alternative splicing of fibroblast growth factor receptor 2 (FGF-R2) in human prostate cancer.
-
An FGF autocrine loop initiated in second heart field mesoderm regulates morphogenesis at the arterial pole of the heart.
-
An interaction between the III-IV linker and CTD in NaV1.5 confers regulation of inactivation by CaM and FHF.
-
Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study.
-
Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease.
-
BMP signaling in the epiblast is required for proper recruitment of the prospective paraxial mesoderm and development of the somites.
-
Biomarkers of Mineral and Bone Metabolism and 20-Year Risk of Hospitalization With Infection: The Atherosclerosis Risk in Communities Study.
-
Bmp signaling regulates proximal-distal differentiation of endoderm in mouse lung development.
-
Bmp4 and Fgf10 play opposing roles during lung bud morphogenesis.
-
Branching out: origins of the sea urchin larval skeleton in development and evolution.
-
Burosumab for the Treatment of Tumor-Induced Osteomalacia.
-
Cardioprotective proteins upregulated in the liver in response to experimental myocardial ischemia.
-
Case report: aplasia of the lacrimal and major salivary glands (ALSG).
-
Casein kinase 1 regulates Sprouty2 in FGF-ERK signaling.
-
Characterization of the murine BEK fibroblast growth factor (FGF) receptor: activation by three members of the FGF family and requirement for heparin.
-
Chordin and noggin promote organizing centers of forebrain development in the mouse.
-
Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.
-
Comparison of the expression of three highly related genes, Fgf8, Fgf17 and Fgf18, in the mouse embryo.
-
Conditional knockout of Fgf13 in murine hearts increases arrhythmia susceptibility and reveals novel ion channel modulatory roles.
-
Cord Blood Ferritin and Fibroblast Growth Factor-23 Levels in Neonates.
-
Coronary artery disease and the thrombospondin single nucleotide polymorphisms.
-
Correlates of left ventricular mass in chronic hemodialysis recipients.
-
Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease.
-
Crystal structure of the ternary complex of a NaV C-terminal domain, a fibroblast growth factor homologous factor, and calmodulin.
-
Current view on regulation of voltage-gated sodium channels by calcium and auxiliary proteins.
-
Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol.
-
Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization.
-
Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestry.
-
Disordered FGF23 and mineral metabolism in children with CKD.
-
Disorders of phosphorus homeostasis.
-
Disruption of Fgf13 causes synaptic excitatory-inhibitory imbalance and genetic epilepsy and febrile seizures plus.
-
Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm.
-
Distinct requirements for extra-embryonic and embryonic bone morphogenetic protein 4 in the formation of the node and primitive streak and coordination of left-right asymmetry in the mouse.
-
Divide, multitask, and conquer: Coordination in channel regulation.
-
Does a rise in plasma erythropoietin after high-altitude exposure affect FGF23 in healthy volunteers on a normal or low-phosphorus diet?
-
Dysregulated mineral metabolism in patients with acute kidney injury and risk of adverse outcomes.
-
Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease.
-
Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.
-
Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials.
-
Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial.
-
Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial.
-
Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD.
-
Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.
-
Effects of keratinocyte growth factor-2 (KGF-2) on wound healing in an ischaemia-impaired rabbit ear model and on scar formation.
-
Effects of phosphate binders in moderate CKD.
-
Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis.
-
Elevated FGF-23 in a patient with rhabdomyolysis-induced acute kidney injury.
-
Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality.
-
Emergence of the keratinocyte growth factor multigene family during the great ape radiation.
-
Enforced expression of FGF-7 promotes epithelial hyperplasia whereas a dominant negative FGFR2iiib promotes the emergence of neuroendocrine phenotype in prostate glands of transgenic mice.
-
Epidemiologic insights on the role of fibroblast growth factor 23 in cardiovascular disease.
-
Evidence basis for integrated management of mineral metabolism in patients with end-stage renal disease.
-
Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement.
-
Evidence that autocrine signaling through Bmpr1a regulates the proliferation, survival and morphogenetic behavior of distal lung epithelial cells.
-
Evolution and development of the mammalian dentition: insights from the marsupial Monodelphis domestica.
-
Evolving revascularization approaches for myocardial ischemia.
-
Exposure to organophosphates reduces the expression of neurotrophic factors in neonatal rat brain regions: similarities and differences in the effects of chlorpyrifos and diazinon on the fibroblast growth factor superfamily.
-
Expression and possible function of fibroblast growth factor 9 (FGF9) and its cognate receptors FGFR2 and FGFR3 in postnatal and adult retina.
-
Expression of bone morphogenetic protein-4 (BMP-4), bone morphogenetic protein-7 (BMP-7), fibroblast growth factor-8 (FGF-8) and sonic hedgehog (SHH) during branchial arch development in the chick.
-
Expression of fgf23 and αklotho in developing embryonic tissues and adult kidney of the zebrafish, Danio rerio.
-
Expression of growth factor and growth factor receptor RNA in rat pleural mesothelial cells in culture.
-
FGF signaling regulates rod photoreceptor cell maintenance and regeneration in zebrafish.
-
FGF signals guide migration of mesenchymal cells, control skeletal morphogenesis [corrected] and regulate gastrulation during sea urchin development.
-
FGF-23 levels in patients with AKI and risk of adverse outcomes.
-
FGF-23: More than a regulator of renal phosphate handling?
-
FGF12 is a candidate Brugada syndrome locus.
-
FGF13 modulates the gating properties of the cardiac sodium channel Nav1.5 in an isoform-specific manner.
-
FGF14 modulates resurgent sodium current in mouse cerebellar Purkinje neurons.
-
FGF14 regulates presynaptic Ca2+ channels and synaptic transmission.
-
FGF21-FGFR1 Coordinates Phospholipid Homeostasis, Lipid Droplet Function, and ER Stress in Obesity.
-
FGF21-FGFR4 signaling in cardiac myocytes promotes concentric cardiac hypertrophy in mouse models of diabetes.
-
FGF23 (Fibroblast Growth Factor-23) and Incident Hypertension in Young and Middle-Aged Adults: The CARDIA Study.
-
FGF23 and Left Ventricular Hypertrophy in Children with CKD.
-
FGF23 and Nutritional Metabolism.
-
FGF23 at the crossroads of phosphate, iron economy and erythropoiesis.
-
FGF23 in chronic kidney disease.
-
FGF23 induces left ventricular hypertrophy.
-
FGF23 modifies the relationship between vitamin D and cardiac remodeling.
-
FGF23 or PTH: which comes first in CKD ?
-
FGF23/FGFR4-mediated left ventricular hypertrophy is reversible.
-
FGF23: fashion or physiology?
-
Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease.
-
Fgf signaling instructs position-dependent growth rate during zebrafish fin regeneration.
-
Fgf-dependent depletion of microRNA-133 promotes appendage regeneration in zebrafish.
-
Fgf9 induces proliferation and nuclear localization of FGFR2 in Sertoli precursors during male sex determination.
-
Fgfs control homeostatic regeneration in adult zebrafish fins.
-
Fibroblast Growth Factor 23 Associates with Death in Critically Ill Patients.
-
Fibroblast Growth Factor 23 Is Associated With Carotid Plaque Presence and Area: The Northern Manhattan Study.
-
Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study.
-
Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness.
-
Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO Study.
-
Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study.
-
Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study.
-
Fibroblast Growth Factor 23 and Exercise Capacity in Heart Failure with Preserved Ejection Fraction.
-
Fibroblast Growth Factor 23 and Incident Cardiovascular Disease and Mortality in Middle-Aged Adults.
-
Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease.
-
Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
-
Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study.
-
Fibroblast Growth Factor 23, Mineral Metabolism, and Adiposity in Normal Kidney Function.
-
Fibroblast Growth Factor Homologous Factors: New Roles in Neuronal Health and Disease.
-
Fibroblast Growth Factor-23 (FGF-23) Levels Differ Across Populations by Degree of Industrialization.
-
Fibroblast Growth Factor-23 Fans the Flames of Heart and Kidney Failure.
-
Fibroblast Growth Factor-23 and a Vegetarian Diet.
-
Fibroblast Growth Factor-23, Heart Failure Risk, and Renin-Angiotensin-Aldosterone-System Blockade in Hypertension: The MESA Study.
-
Fibroblast growth factor 10 (FGF10) and branching morphogenesis in the embryonic mouse lung.
-
Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease.
-
Fibroblast growth factor 21 mediates specific glucagon actions.
-
Fibroblast growth factor 23 and Inflammation in CKD.
-
Fibroblast growth factor 23 and incident CKD in type 2 diabetes.
-
Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.
-
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.
-
Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.
-
Fibroblast growth factor 23 and the future of phosphorus management.
-
Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.
-
Fibroblast growth factor 23 in patients undergoing peritoneal dialysis.
-
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.
-
Fibroblast growth factor 23 is not associated with and does not induce arterial calcification.
-
Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery.
-
Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study.
-
Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.
-
Fibroblast growth factor homologous factor 13 regulates Na+ channels and conduction velocity in murine hearts.
-
Fibroblast growth factor homologous factors in the heart: a potential locus for cardiac arrhythmias.
-
Fibroblast growth factor homologous factors modulate cardiac calcium channels.
-
Fibroblast growth factor homologous factors tune arrhythmogenic late NaV1.5 current in calmodulin binding-deficient channels.
-
Fibroblast growth factor signaling in the developing tracheoesophageal fistula.
-
Fibroblast growth factor-23 and cardiovascular events in CKD.
-
Fibroblast growth factor-23 and subclinical markers of cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study.
-
Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.
-
Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart disease.
-
Fibroblast growth factor-23-mediated inhibition of renal phosphate transport in mice requires sodium-hydrogen exchanger regulatory factor-1 (NHERF-1) and synergizes with parathyroid hormone.
-
Fibroblast growth factor23 is associated with axonal integrity and neural network architecture in the human frontal lobes.
-
Fluorescence in situ hybridization analysis of keratinocyte growth factor gene amplification and dispersion in evolution of great apes and humans.
-
Forging forward with 10 burning questions on FGF23 in kidney disease.
-
Fusion of fibroblast growth factor 21 to a thermally responsive biopolymer forms an injectable depot with sustained anti-diabetic action.
-
GFR-Specific versus GFR-Agnostic Cutoffs for Parathyroid Hormone and Fibroblast Growth Factor-23 in Advanced Chronic Kidney Disease.
-
Gene expression profiling of microsatellite unstable and microsatellite stable endometrial cancers indicates distinct pathways of aberrant signaling.
-
Gene-gene interaction between FGF20 and MAOB in Parkinson disease.
-
Genetic Variants Associated with Circulating Fibroblast Growth Factor 23.
-
Genetic background influences cardiac phenotype in murine chronic kidney disease.
-
Genome-wide meta-analysis of macronutrient intake of 91,114 European ancestry participants from the cohorts for heart and aging research in genomic epidemiology consortium.
-
Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake.
-
Growth factors for therapeutic angiogenesis in peripheral arterial disease.
-
Haptotactic gradients for directed cell migration: stimulation and inhibition using soluble factors.
-
Hedgehog inhibits β-catenin activity in synovial joint development and osteoarthritis.
-
Heterochrony in somitogenesis rate in a model marsupial, Monodelphis domestica.
-
High-density lipoprotein maintains skeletal muscle function by modulating cellular respiration in mice.
-
Hypophosphatemia after intravenous iron therapy: Comprehensive review of clinical findings and recommendations for management.
-
Hypophosphatemic rickets in opsismodysplasia.
-
Identification and requirements of enhancers that direct gene expression during zebrafish fin regeneration.
-
Identification of novel interaction sites that determine specificity between fibroblast growth factor homologous factors and voltage-gated sodium channels.
-
Impact of westernization on fibroblast growth factor 23 levels among individuals of African ancestry.
-
Increased expression of fibroblast growth factors in a rabbit skeletal muscle model of exercise conditioning.
-
Inducible Fgf13 ablation enhances caveolae-mediated cardioprotection during cardiac pressure overload.
-
Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.
-
Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production.
-
Is FGF13 a major contributor to genetic epilepsy with febrile seizures plus?
-
KLB is associated with alcohol drinking, and its gene product β-Klotho is necessary for FGF21 regulation of alcohol preference.
-
Keratinocyte growth factor--just another mitogen or the "Holy Grail" that regulates liver regeneration?
-
Kidney to bone via bedside to bench…and back?
-
Klotho Inhibits Interleukin-8 Secretion from Cystic Fibrosis Airway Epithelia.
-
Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.
-
Knockout of the X-linked Fgf13 in the hypothalamic paraventricular nucleus impairs sympathetic output to brown fat and causes obesity.
-
Laser-assisted delivery of vitamin C, vitamin E, and ferulic acid formula serum decreases fractional laser postoperative recovery by increased beta fibroblast growth factor expression.
-
Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
-
Longitudinal FGF23 Trajectories and Mortality in Patients with CKD.
-
Maintenance of blastemal proliferation by functionally diverse epidermis in regenerating zebrafish fins.
-
Male-to-female sex reversal in mice lacking fibroblast growth factor 9.
-
Mineral (Mal)Adaptation to Kidney Disease--Young Investigator Award Address: American Society of Nephrology Kidney Week 2014.
-
Mineral metabolites and CKD progression in African Americans.
-
Mixed signals: development of the testis.
-
Morphogenesis.
-
Msx1 and Pax3 cooperate to mediate FGF8 and WNT signals during Xenopus neural crest induction.
-
NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis.
-
NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
-
Nephropathic Cystinosis: A Distinct Form of CKD-Mineral and Bone Disorder that Provides Novel Insights into the Regulation of FGF23.
-
Neurogenesis in the sea urchin embryo is initiated uniquely in three domains.
-
Neuronal regulation of the spatial patterning of neurogenesis.
-
Novel role for Netrins in regulating epithelial behavior during lung branching morphogenesis.
-
Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet.
-
Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.
-
Phosphate: a novel cardiovascular risk factor.
-
Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease.
-
Pivoting From PTH to FGF23 to Mend Breaking Hearts on Dialysis.
-
Plant protein intake is associated with fibroblast growth factor 23 and serum bicarbonate levels in patients with chronic kidney disease: the Chronic Renal Insufficiency Cohort study.
-
Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS).
-
Plasma FGF23 levels increase rapidly after acute kidney injury.
-
Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?
-
Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD.
-
Prolonged Correction of Serum Phosphorus in Adults With X-Linked Hypophosphatemia Using Monthly Doses of KRN23.
-
Pruning the ricket thicket.
-
R-spondin1 tips the balance in sex determination.
-
Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis.
-
Racial Differences in the Associations Between Food Insecurity and Fibroblast Growth Factor 23 in the Coronary Artery Risk Development in Young Adults Study.
-
Racial differences in postprandial mineral ion handling in health and in chronic kidney disease.
-
Randomised clinical trial of ferric citrate hydrate on anaemia management in haemodialysis patients with hyperphosphataemia: ASTRIO study.
-
Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design.
-
Randomized trial of intravenous iron-induced hypophosphatemia.
-
Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia.
-
Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.
-
Recent advances in the rapidly evolving field of fibroblast growth factor 23 in chronic kidney disease.
-
Regulated addition of new myocardial and epicardial cells fosters homeostatic cardiac growth and maintenance in adult zebrafish.
-
Regulation and Effects of FGF23 in Chronic Kidney Disease.
-
Reiterative roles for FGF signaling in the establishment of size and proportion of the zebrafish heart.
-
Response to Letter to the Editor: "Fibroblast Growth Factor 23, Mineral Metabolism, and Adiposity in Normal Kidney Function".
-
Role for ETS domain transcription factors Pea3/Erm in mouse lung development.
-
Roles for Fgf signaling during zebrafish fin regeneration.
-
Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.
-
SCN5A variant that blocks fibroblast growth factor homologous factor regulation causes human arrhythmia.
-
SHP-2 is required for the maintenance of cardiac progenitors.
-
Second chances in mineral metabolism.
-
Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study.
-
Serum FGF23 levels in normal and disordered phosphorus homeostasis.
-
Serum levels of fibroblast growth factor 23 are elevated in patients with active Lupus nephritis.
-
Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD.
-
Sleep disordered breathing and fibroblast growth factor 23 in the Hispanic Community Health Study/Study of Latinos.
-
Specific blockade of basic fibroblast growth factor gene expression in endothelial cells by antisense oligonucleotide.
-
Specification of epibranchial placodes in zebrafish.
-
Sphingosine-1-phosphate signaling regulates lamellipodia localization of cortactin complexes in endothelial cells.
-
Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks.
-
Structural analyses of Ca²⁺/CaM interaction with NaV channel C-termini reveal mechanisms of calcium-dependent regulation.
-
Studies on the role of basic fibroblast growth factor in vivo: inability of neutralizing antibodies to block tumor growth.
-
Sugar-sweetened beverage intake associations with fasting glucose and insulin concentrations are not modified by selected genetic variants in a ChREBP-FGF21 pathway: a meta-analysis.
-
Sustained release of a GLP-1 and FGF21 dual agonist from an injectable depot protects mice from obesity and hyperglycemia.
-
Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis.
-
Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b.
-
Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation.
-
The BMP antagonists Chordin and Noggin have essential but redundant roles in mouse mandibular outgrowth.
-
The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans.
-
The biomarker niche for fibroblast growth factor 23 testing in CKD.
-
The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia.
-
The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?
-
The protective effect of recombinant human keratinocyte growth factor on radiation-induced pulmonary toxicity in rats.
-
The role of chordin/Bmp signals in mammalian pharyngeal development and DiGeorge syndrome.
-
The role of peptide growth factors in epithelial ovarian cancer.
-
Tissue interactions pattern the mesenchyme of the embryonic mouse lung.
-
Transient laminin beta 1a Induction Defines the Wound Epidermis during Zebrafish Fin Regeneration.
-
Tumor-induced osteomalacia masking primary hyperparathyroidism.
-
Twist is an integrator of SHH, FGF, and BMP signaling.
-
Unrelated developmental neurotoxicants elicit similar transcriptional profiles for effects on neurotrophic factors and their receptors in an in vitro model.
-
Update on Chronic Kidney Disease Mineral and Bone Disorder in Cardiovascular Disease.
-
Update on fibroblast growth factor 23 in chronic kidney disease.
-
Updating the Wnt pathways.
-
Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein.
-
rHuKGF ameliorates symptoms in DSS and CD4(+)CD45RB(Hi) T cell transfer mouse models of inflammatory bowel disease.
-
αKlotho: FGF23 coreceptor and FGF23-regulating hormone.
-
Keywords of People
-
Adkins, Deanna Wilson,
Associate Professor of Pediatrics,
Pediatrics, Endocrinology
-
Berchuck, Andrew,
James M. Ingram Distinguished Professor of Gynecologic Oncology,
Obstetrics and Gynecology, Gynecologic Oncology
-
Hogan, Brigid L. M.,
Research Professor of Cell Biology,
Cell Biology
-
Pitt, Geoffrey Stuart,
Adjunct Professor in the Department of Medicine,
Medicine, Cardiology